Effect of Reserpine on the Behavioral Defects, Aβ-42 Deposition and NGF Metabolism in Tg2576 Transgenic Mouse Model for Alzheimer's Disease |
Go, Jun
(Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University)
Choi, Sun Il (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) Kim, Ji Eun (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) Lee, Young Ju (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) Kwak, Moon Hwa (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) Koh, Eun Kyoung (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) Song, Sung Hwa (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) Sung, Ji Eun (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) Hwang, Dae Youn (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University) |
1 | Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. DOI ScienceOn |
2 | Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., Cho, J. Y., Hong, J. T., Song, C. W., Paik, S. G., Cho, J. S. and Kim, Y. K. 2002. Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J 16, 805-813. DOI ScienceOn |
3 | Iwatsubo, T. 2004. The -secretase complex: machinery for intramembrane proteolysis. Curr Opin Neurobiol 14, 379-383. DOI ScienceOn |
4 | Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S. and Malinow, R. 2003. APP processing and synaptic function. Neuron 37, 925-937. DOI ScienceOn |
5 | Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S. and Selkoe, D. J. 2003. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, And Pen-2. Proc Natl Acad Sci USA 100, 6382-6387. DOI ScienceOn |
6 | King, D. L. and Arendash, G. W. 2002. Behavioral characterization of the Tg2576 transgenic model of Alzheimer’s disease through 19 months. Physiol Behav 75, 627-642. DOI ScienceOn |
7 | Kirshner, N. 1962. Uptake of catecholamines by a particulate fraction of the adrenal medulla. J Biol Chem 237, 2311-2317. |
8 | Kirshner, N. 1962. Uptake of catecholamines by a particulate fraction of the adrenal medulla. Science 135, 107-108. DOI ScienceOn |
9 | Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K. and Yankner, B. A. 1991. An in vivo model for the neurodegenerative effects of amyloid and protection by substance P. Proc Nat Acad Sci USA 88, 7247-7251. DOI ScienceOn |
10 | Levitan, D., Lee, J., Song, L., Manning, R., Wong, G., Parker, E. and Zhang, L. 2001. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc Natl Acad Sci USA 98, 12186-12190. DOI ScienceOn |
11 | Link, C. D. 1995. Expression of human-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci 92, 9368-9372. DOI |
12 | Li, Y. M., Lai, M. T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. K., Shi, X. P., Yin, K. C., Shafer, J. A. and Gardell, S. J. 2000. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 97, 6138-6143. DOI ScienceOn |
13 | Lopez-Munoz, F., Bhatara, V. S., Alamo, C. and Cuenca, E. 2004. Historical approach to reserpine discovery and its introduction in psychiatry. Actas Esp Psiquiatr 32, 387-395. |
14 | Luo, W. J., Wang, H., Li, H., Kim, B. S., Shah, S., Lee, H. J., Thinakaran, G., Kim, T. W., Yu, G. and Xu, H. 2003. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J Biol Chem 278, 7850-7854. DOI ScienceOn |
15 | Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R. E. 1992. -Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neuro Sci 12, 376-389. |
16 | Perini, G., Della-Bianca, V., Politi, V., Della, V. G., Dal-Pra, I., Rossi, F. and Armato, U. 2002. Role of p75 neurotrophin receptor in the neurotoxicity by -amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 195, 907-918. DOI |
17 | Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W. 1993. Neurodegeneration induced by -amyloid peptides in vitro: the role of peptide assembly state. J Neuro Sci 13, 1676-1687. |
18 | Prajapati, K. D., Sharma, S. S. and Roy, N. 2010. Upregulation of albumin expression in focal ischemic rat brain. Brain Res 1327, 118-124. DOI ScienceOn |
19 | Russo, C., Dolcini, V., Salis, S., Venezia, V., Zambrano, N., Russo, T. and Schettini, G. 2002. Signal transduction through tyrosine-phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. J Biol Chem 277, 35282-35288. DOI ScienceOn |
20 | Rizarry, M., McNamara, M., Fedorchack, K., Hsiao, K. and Hyman, B. 1997. APPsw transgenic mice develop age-related Ab deposits and neurophil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neuro 56, 965-973. DOI |
21 | Saharia, K., Arya, U., Kumar, R., Sahu, R., Das, C. K., Gupta, K., Dwivedi, H. and Subramaniam, J. R. 2012. Reserpine modulates neurotransmitter release to extend lifespan and alleviate age-dependent A proteotoxicity in Caenorhabditis elegans. Exp Gerontol 47, 188-197. DOI ScienceOn |
22 | Salehi, A., Delcroix, J. D. and Swaab, D. F. 2004. Alzheimer's disease and NGF signaling. J Neural Transm 111, 323-345. DOI ScienceOn |
23 | Shearman, M. S., Ragan, C. I. and Iversen, L. 1994. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of -amyloid-mediated cell death. Proc Natl Acad Sci USA 91, 1470-1474. DOI ScienceOn |
24 | Slotkin, T. A. and Edwards, K. 1973. Effects of reserpine on the content and properties of rat adrenal medullary storage vesicles. Biochem Pharmacol 22, 549-560. DOI ScienceOn |
25 | Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. 2002. PEN-2 is an integral component of the -secretase complex required for coordinated expression of presenilin and nicastrin. J Biol Chem 277, 39062-39065. DOI ScienceOn |
26 | Susen, K. and Blöchl, A. 2005. Low concetrations of aggregated -amyloid induce neurite formation via the neurotrophin receptor p75. J Mol Med 83, 720-735. DOI |
27 | Tsui-Pierchala, B. A. and Ginty, D. D. 1999. Characterization of an NGF–P-TrkA retrograde-signaling complex and age-dependent regulation of TrkA phosphorylation in sympathetic neurons. J Neurosci 19, 8207-8218. |
28 | Takashima, A., Noguchi, K., Sato, K., Hoshino, T. and Imahori, K. 1993. Tau protein kinase I is essential for amyloid -protein-induced neurotoxicity. Proc Natl Acad Sci USA 90, 7789-7793. DOI |
29 | Tarr, P. E., Roncarati, R., Pelicci, G., Pelicci, P. G. and D'Adamio, L. 2002. Tyrosine phosphorylation of the -amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J Biol Chem 277, 16798-16804. DOI ScienceOn |
30 | Thind, K. and Sabbagh, M. N. 2007. Pathological correlates of cognitive decline in Alzheimer's disease. Panminerva Med 49, 191-195. |
31 | Vakil, R. J. 1949. A clinical trial of Rauwolfia serpentina in essential hypertension. Br Heart J 11, 350-355. DOI |
32 | Wasling, P., Daborg, J., Riebe, I., Andersson, M., Portelius, E., Blennow, K., Hanse, E. and Zetterberg, H. 2009. Synaptic retrogenesis and amyloid-beta in Alzheimer's disease. J Alzheimers Dis 16, 1-14. |
33 | Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T. and Selkoe, D. J. 1999. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and -secretase activity. Nature 398, 513-517. DOI ScienceOn |
34 | Yankner, B. A., Duffy, L. K. and Kirschner, D. A. 1990. Neurotrophic and neurotoxic effects of amyloid -protein: reversal by tachykinin neuropeptides. Science 250, 279-282. DOI ScienceOn |
35 | Blennow, K., de Leon, M. J. and Zetterberg, H. 2006. Alzheimer's disease. Lancet 368, 387-403. DOI ScienceOn |
36 | Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y. Q., Rogaeva, E., Chen, F., Kawarai, T., Supala, A., Levesque, L., Yu, H., Yang, D. S., Holmes, E., Milman, P., Liang, Y., Zhang, D. M., Xu, D. H., Sato, C., Rogaev, E., Smith, M., Janus, C., Zhang, Y., Aebersold, R., Farrer, L. S., Sorbi, S., Bruni, A., Fraser, P. and St George-Hyslop, P. 2000. Nicastrin modulates presenilinmediated notch/glp-1 signal transduction and APP processing. Nature 407, 48-54. DOI ScienceOn |
37 | Ahn, K., Shelton, C. C., Tian, Y., Zhang, X., Gilchrist, M. L., Sisodia, S. S. and Li, Y. M. 2010. Activation and intrinsic gamma-secretase activity of presenilin 1. Proc Natl Acad Sci USA 107, 21435-21440. DOI ScienceOn |
38 | Arendt, T. 2009. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 118, 167-179. DOI |
39 | Arya, U., Dwivedi, H. and Subramaniam, J. R. 2009. Reserpine ameliorates Abeta toxicity in the Alzheimer's disease model in Caenorhabditis elegans. Exp Gerontol 44, 462-466. DOI ScienceOn |
40 | Behl, C., Davis, J. B., Lesley, R. and Schubert, D. 1994. Hydrogen peroxide mediates amyloid protein toxicity. Cell 77, 817-827. DOI ScienceOn |
41 | Cavallucci, V., D’Amelio, M. and Cecconi, F. 2012. A toxicity in Alzheimer’s disease. Mol Neurobiol 45, 366-378. DOI ScienceOn |
42 | Bleuler, M. and Stoll, W. A. 1955. Clinical use of reserpine in psychiatry: comparison with chlorpromazine. Ann N Y Acad Sci 61, 167-173. DOI ScienceOn |
43 | Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C. M., Kim, G., Seekin, S., Yager, D., Slunt, H. H., Wang, R., Seeger, M., Levey, A. I., Gandy, S. E., Copeland, N. G., Jenkins, N. A., Price, D. L., Younkin, S. G. and Sisodia, S. S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta 1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013. |
44 | Carmichael, S. W., Weber, A. and Winkler, H. 1980. Uptake of nucleotides and catecholamines by chromaffin granules from pig and horse adrenal medulla. J Neurochem 35, 270-272. DOI |
45 | Cerejeira, J., Lagarto, L. and Mukaetova-Ladinska, E. B. 2012. Behavioral and psychological symptoms of Dementia. Front Neurol 3, 1-21. |
46 | Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D. J. 1992. Mutation of the -amyloid precursor protein in familial Alzheimer's disease increases protein production. Nature 360, 672-674. DOI ScienceOn |
47 | di Mola, F. F., Friess, H., Zhu, Z. W., Koliopanos, A., Bley, T., Di sebastiano, P., Innocenti, P., Zimmermann, A. and Bu chler, M. W. 2000. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 46, 670-679. DOI |
48 | Einarsdottir, E., Carlsson, A., Minde, J., Toolanen, G., Svensson, O., Solders, G., Holmgren, G., Holmberg, D. and Holmberg, M. 2004. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet 13, 799-805. DOI ScienceOn |
49 | Fabrazzo, M., Costa, E. and Mocchetti, I. 1991. Stimulation of nerve growth factor biosynthesis in developing rat brain by reserpine: steroids as potential mediators. Mol Pharmacol 39, 144-149. |
50 | Frautschy, S. A., Baird, A. and Cole, G. M. 1991. Effects of injected Alzheimer -amyloid cores in rat brain. Proc Natl Acad Sci USA 88, 8362-8266. DOI |
51 | Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B., Saido, T., Hsiao, K. and Cole, G. 1998. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 152, 307-317. |
52 | Freund-Michel, V. and Frossard, N. 2008. The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther 117, 52-76. DOI ScienceOn |
53 | Fujiwara, H., Takayama, S., Iwasaki, K., Tabuchi, M., Yamaguchi, T., Sekiguchi, K., Ikarashi, Y., Kase, Y., Arai, H. and Yaegashi, N. 2011. Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid proteins in amyloid precursor protein transgenic mice. Neuroscience 180, 305-313. DOI ScienceOn |
54 | Goedert, M. and Spillantini, M. G. 2006. A century of Alzheimer's disease. Science 314, 777-781. DOI ScienceOn |
55 | Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L. and Selkoe, D. J. 1995. The Swedish mutation causes earlyonset Alzheimer's disease by -secretase cleavage within the secretory pathway. Nature Med 1, 1291-1296. DOI ScienceOn |
56 | Heese, K., Low, J. W. and Inoue, N. 2006. Nerve growth factor, Neural stem cells and Alzheimer's disease. Neurosignals 15, 1-12. DOI ScienceOn |
57 | Henry, J. P., Gasnier, B., Roisin, M. P., Isambert, M. F. and Scherman, D. 1987. Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane. Ann N Y Acad Sci 493, 194-206. DOI |
58 | Henry, J. P., Sagne, C., Botton, D., Isambert, M. F. and Gasnier, B. 1998. Molecular pharmacology of the vesicular monoamine transporter. Adv Pharmacol 42, 236-239. |